Beat
Startups
Follow this beat in any feed reader: RSS
Greenoaks and Sequoia co-led the round, with Andreessen Horowitz joining as a new backer, while the Alphabet unit still has no approved drug.
The Guardian reports 825m class A shares go on sale, with final pricing set Wednesday and Nasdaq trading starting Thursday. UK retail platforms are taking applications.
The Information's briefing headline gives the figure, but the text available to us does not explain the deal, its timing or who is buying.
The DeepMind spinout did not disclose its valuation, though Bloomberg reported it was seeking funding at a $50 billion valuation.
Order books close at 4 p.m. ET Tuesday, with trading as "ANT" on Nasdaq set to start Nov. 19, according to unnamed people familiar with the plan.